Aflibercept to Improve Visual Acuity in Diabetic Macular Edema Aflibercept to Improve Visual Acuity in Diabetic Macular Edema

Among the available anti-vascular endothelial growth factor (VEGF) therapies, aflibercept appears to offer the greatest improvement in visual acuity in patients with diabetic macular edema (DME) and worse baseline vision.Reuters Health Information

Source: Medscape Ophthalmology Headlines - October 11, 2016 Category: Opthalmology Tags: Ophthalmology News Source Type: news